New Weight Loss Drug Retatrutide Delivers Stunning Results


  • Surgeon General Issues Suggested Screen Time Limits for Kids

    04:27

  • David Letterman Talks End of ‘Late Show,’ Indy500, Heart Health

    05:22

  • New Mexico Hazmat Emergency Leaves 3 Dead

    00:31

  • Now Playing

    New Weight Loss Drug Retatrutide Delivers Stunning Results

    03:13

  • UP NEXT

    Detroit-Bound Plane Diverted to Canada Over Ebola Concerns

    02:00

  • Olympic Gold Medalists Give Lesson in Swim Safety Ahead of Summer

    04:20

  • What Are the Benefits of Adding Peptides to Your Daily Routine?

    04:50

  • Health Officials Race to Trace Rising Ebola Cases in Central Africa

    02:07

  • How to Navigate a Break-Up With a Friend

    04:10

  • How Women Can Prioritize Health — and What to Check Annually

    05:09

  • What is ‘Ozempic Personality’? How GLP-1s Can Affect Mood

    05:26

  • American Doctor Infected With Ebola While Working in Congo

    01:20

  • Straus Family Creamery Ice Cream Recalled for Metal Fragments

    00:28

  • How to Encourage Mental Health Conversations With Your Teen

    06:05

  • Tips for Understanding and Managing Your Blood Pressure

    04:55

  • Ebola Outbreak in Congo and Uganda Declared Global Emergency

    00:31

  • Hantavirus Cruise Ship Arrives in Netherlands to Be Disinfected

    02:08

  • Dr. Edith Eger, Holocaust Survivor and Psychologist, Dies at 98

    02:19

  • Easy Workouts to Build Strength in Core, Legs, Arms at Any Age

    05:04

  • Jackie Tohn Opens up About Her Health Scare With Breast Cancer

    07:58

Remarkable new test results by drugmaker Eli Lilly reveal that their latest weight loss drug, retatrutide, may be even more effective than the three popular GLP-1s currently available. The new drug is designed to mimic three hormones responsible for hunger regulation and fat burning. NBC’s medical contributor Dr. Natalie Azar breaks down the trial results and discusses how soon the new drug is likely to get FDA approval.



Source link

  • Related Posts

    Rep. Tom Kean hasn’t been seen in his N.J. district, where voters are split on his mysterious absence

    GOP leaders have expressed confidence that Kean will be able to run and win in November. However, even House Speaker Mike Johnson, R-La., who said he last spoke to the…

    OpenTable Announces Canadian Expansion with New Toronto Office Lease

    “Restaurants are at the heart of Canadian communities and local economies, and as the country’s fourth largest private sector employer,* they need partners who are equally invested in their success,”…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Thunder vs. Spurs is turning into a war of attrition, which favors OKC … and the East

    Thunder vs. Spurs is turning into a war of attrition, which favors OKC … and the East

    Scientists discover hidden weakness shared by hundreds of cancer mutations

    Scientists discover hidden weakness shared by hundreds of cancer mutations

    No evidence of formal security vetting when Andrew became UK trade envoy, minister says | Andrew Mountbatten-Windsor

    No evidence of formal security vetting when Andrew became UK trade envoy, minister says | Andrew Mountbatten-Windsor

    Rep. Tom Kean hasn’t been seen in his N.J. district, where voters are split on his mysterious absence

    Rep. Tom Kean hasn’t been seen in his N.J. district, where voters are split on his mysterious absence

    Russian Hackers Are Inside American Home Routers. The FBI Has a 5-Step Fix

    Russian Hackers Are Inside American Home Routers. The FBI Has a 5-Step Fix

    Dragon Age: Inquisition's lead narrative designer is making an adventure game world "where the ordinary starts to feel like it is hiding something"

    Dragon Age: Inquisition's lead narrative designer is making an adventure game world "where the ordinary starts to feel like it is hiding something"